These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 33745433)
1. Single-cell RNA Sequencing Analysis Identifies Key Genes in Brain Metastasis from Lung Adenocarcinoma. Zhang Z; Cui F; Zhou M; Wu S; Zou Q; Gao B Curr Gene Ther; 2021; 21(4):338-348. PubMed ID: 33745433 [TBL] [Abstract][Full Text] [Related]
2. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis. Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311 [TBL] [Abstract][Full Text] [Related]
3. An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer. Tsakonas G; Lewensohn R; Botling J; Ortiz-Villalon C; Micke P; Friesland S; Nord H; Lindskog M; Sandelin M; Hydbring P; Ekman S Eur J Cancer; 2020 Jun; 132():24-34. PubMed ID: 32325417 [TBL] [Abstract][Full Text] [Related]
4. Gene Expression Profile in Primary Tumor Is Associated with Brain-Tropism of Metastasis from Lung Adenocarcinoma. Lin YY; Wang YC; Yeh DW; Hung CY; Yeh YC; Ho HL; Mon HC; Chen MY; Wu YC; Chou TY Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948172 [TBL] [Abstract][Full Text] [Related]
5. Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples. Dong S; Men W; Yang S; Xu S Oncol Rep; 2020 May; 43(5):1437-1450. PubMed ID: 32323809 [TBL] [Abstract][Full Text] [Related]
6. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis. Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076 [TBL] [Abstract][Full Text] [Related]
7. Identification of differential protein-coding gene expressions in early phase lung adenocarcinoma. Zhou LN; Li SC; Li XY; Ge H; Li HM Thorac Cancer; 2018 Feb; 9(2):234-240. PubMed ID: 29266838 [TBL] [Abstract][Full Text] [Related]
8. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma. Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504 [TBL] [Abstract][Full Text] [Related]
9. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer. Liu X; Liu X; Li J; Ren F Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030 [TBL] [Abstract][Full Text] [Related]
10. POLE2 Serves as a Prognostic Biomarker and Is Associated with Immune Infiltration in Squamous Cell Lung Cancer. Wu Z; Wang YM; Dai Y; Chen LA Med Sci Monit; 2020 Apr; 26():e921430. PubMed ID: 32304567 [TBL] [Abstract][Full Text] [Related]
11. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis. Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972 [TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer. Chen J; Wu R; Xuan Y; Jiang M; Zeng Y Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465 [TBL] [Abstract][Full Text] [Related]
13. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses. Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma. Li J; Liu X; Cui Z; Han G Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582 [TBL] [Abstract][Full Text] [Related]
15. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development. Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325 [TBL] [Abstract][Full Text] [Related]
16. Development and validation of a five-gene model to predict postoperative brain metastasis in operable lung adenocarcinoma. Fu F; Zhang Y; Gao Z; Zhao Y; Wen Z; Han H; Li Y; Chen H Int J Cancer; 2020 Jul; 147(2):584-592. PubMed ID: 32181877 [TBL] [Abstract][Full Text] [Related]
17. Bioinformatics analysis reveals 6 key biomarkers associated with non-small-cell lung cancer. Dai B; Ren LQ; Han XY; Liu DJ J Int Med Res; 2020 Mar; 48(3):300060519887637. PubMed ID: 31775549 [TBL] [Abstract][Full Text] [Related]
18. Identification and validation of key genes associated with non-small-cell lung cancer. Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628 [TBL] [Abstract][Full Text] [Related]
19. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma. Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085 [No Abstract] [Full Text] [Related] [Next] [New Search]